Delamanid is a new anti-tuberculosis drug: Use, limitations, and prospects [Деламанид - новый противотуберкулезный препарат: применение, ограничения, перспективы]

The review analyses 61 publications on the use of delamanid, a new drug for the treatment of drug resistant tuberculosis. It presents information about pharmacokinetic parameters, efficacy and safety, as well as the place of delamanid in the combination therapy of multiple drug resistant tuberculosis. It tells about specific parameters of delamanid use in children and HIV patients. © 2021 New Terra Publishing House. All rights reserved.